Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

The frequency of antipsychotic (AP) use during pregnancy has approximately doubled during the last decade. However, little is known about their safety for the developing fetus, and concerns have been raised about a potential association with congenital malformations. To examine the risk for congenit...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	JAMA psychiatry (Chicago, Ill.) Ročník 73; číslo 9; s. 938
Hlavní autoři:	Huybrechts, Krista F, Hernández-Díaz, Sonia, Patorno, Elisabetta, Desai, Rishi J, Mogun, Helen, Dejene, Sara Z, Cohen, Jacqueline M, Panchaud, Alice, Cohen, Lee, Bateman, Brian T
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.09.2016
Témata:	Abnormalities, Drug-Induced - epidemiology Abnormalities, Drug-Induced - etiology Adult Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Cohort Studies Female Heart Defects, Congenital - chemically induced Heart Defects, Congenital - epidemiology Humans Infant, Newborn Medicaid - statistics & numerical data Pregnancy Pregnancy Complications - drug therapy Pregnancy Complications - epidemiology Pregnancy Trimester, First Psychotic Disorders - drug therapy Psychotic Disorders - epidemiology Risk Risperidone - adverse effects Risperidone - therapeutic use United States Young Adult
ISSN:	2168-6238, 2168-6238
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!